SafeSanté secures €12m to create virtual medical centre

  • June 14, 2021
  • Steve Rogerson

French telemedicine firm SafeSanté has secured €12m funding from the Gem Group to democratise its telemedicine IoT offering and create a virtual medical centre.

SafeSanté has specialised in telemedicine since 2014. It has signed an agreement with Gem Global Yield, a Luxemburg-based private alternative investment group, for a €12m capital commitment.

Gem has committed to providing SafeSanté with a share subscription facility of up to €12m for a 36-month term following the public listing of the company shares on a European national stock exchange. SafeSanté will control the timing and maximum amount of drawdown under the facility and has no minimum drawdown obligation. Concurrent to the public listing of SafeSanté shares, Gem will receive warrants to purchase shares of the company.

Subject to the funding becoming available, the proceeds will be used to develop its telemedicine offering in France and Europe with the objective of improving access to care and reducing its barriers.

SafeSanté’s telemedicine offering is aimed at all healthcare professionals, healthcare institutions and patients. It integrates medical devices that allow doctors to examine patients remotely as well as face-to-face, for general or specialised medicine.

“We are very pleased by the Gem commitment and welcome them to this adventure of improving access to care,” said Yonathan Abbou, chairman of SafeSanté. “This funding and becoming a public entity will help us to expand our activities in France and in Europe in several areas. Our vision is to connect patients and healthcare professionals through our digital tools and hi-tech connected devices. Our goal is to build the largest virtual medical centre in Europe in order to give every patient the chance to access quickly to quality care.”

SafeSanté was founded in Paris in 2014 by Abbou, and aims to connect patients and doctors with the best technological tools at its disposal. SafeSanté Doc is already used by many doctors in France who follow their patients remotely. The company has also integrated telemedicine terminals with connected medical devices in pharmacies and health institutions and provided mobile devices for private nurses.

Global Emerging Markets (Gem) is a $3.4bn alternative investment group with operations in Paris, New York and Los Angeles. It manages a diverse set of investment vehicles focused on emerging markets and has completed 400 transactions in 70 countries.